Suppr超能文献

透析患者低密度脂蛋白胆固醇水平与心血管结局的关联:一项全国性队列研究

Associations Between Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Patients Undergoing Dialysis: A Nationwide Cohort Study.

作者信息

Kim Byung Sik, Kim Jiyeong, Choi Nayeon, Kim Hyun-Jin, Shin Jeong-Hun

机构信息

Division of Cardiology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 11923, Republic of Korea.

Biostatistics Lab, Medical Research Collaborating Center, Industry-University Cooperation Foundation, Hanyang University, Seoul 04763, Republic of Korea.

出版信息

J Clin Med. 2025 Jul 8;14(14):4845. doi: 10.3390/jcm14144845.

Abstract

Low-density lipoprotein cholesterol (LDL-C) is a causal factor in the development of atherosclerosis and a predictor of cardiovascular disease. However, the association between LDL-C levels and cardiovascular outcomes in patients undergoing dialysis remains controversial, with current guidelines advising against initiating statin therapy in this population. This study investigated the relationship between LDL-C levels and cardiovascular outcomes in Korean adults undergoing dialysis, using nationwide data. : A total of 21,692 patients with end-stage kidney disease undergoing dialysis between 2009 and 2017 were identified from the Korean National Health Insurance Service database. Statin non-users (primary cohort) and users (secondary cohort) comprised 15,414 and 6278 patients, respectively. LDL-C levels were categorized, and cardiovascular outcomes including composites of cardiovascular death, myocardial infarction, and ischemic stroke were analyzed. : Among statin non-users, LDL-C levels > 100 mg/dL were significantly associated with an increased risk of the composite outcome, in a dose-dependent manner, compared with LDL-C levels < 70 mg/dL. Specifically, participants with LDL-C levels ≥ 160 mg/dL demonstrated a 43% increased risk of the composite outcome and a 2.25-fold higher risk of myocardial infarction compared to those with LDL-C levels < 70 mg/dL. Among statin users, LDL-C levels > 130 mg/dL were associated with an increased risk of the composite outcome. : This study highlights the significant association between elevated LDL-C levels and adverse cardiovascular outcomes in patients undergoing dialysis. These findings underscore the importance of close monitoring and proactive management of LDL-C levels in this high-risk population. Future research should focus on developing tailored lipid-lowering strategies to improve cardiovascular outcomes in these patients.

摘要

低密度脂蛋白胆固醇(LDL-C)是动脉粥样硬化发展的一个致病因素,也是心血管疾病的一个预测指标。然而,透析患者的LDL-C水平与心血管结局之间的关联仍存在争议,目前的指南不建议在这一人群中启动他汀类药物治疗。本研究利用全国性数据调查了韩国透析成年患者的LDL-C水平与心血管结局之间的关系。:从韩国国民健康保险服务数据库中识别出2009年至2017年间共21692例接受透析的终末期肾病患者。未使用他汀类药物者(主要队列)和使用者(次要队列)分别包括15414例和6278例患者。对LDL-C水平进行分类,并分析包括心血管死亡、心肌梗死和缺血性中风在内的心血管结局。:在未使用他汀类药物者中,与LDL-C水平<70mg/dL相比,LDL-C水平>100mg/dL与复合结局风险增加显著相关,且呈剂量依赖性。具体而言,与LDL-C水平<70mg/dL者相比,LDL-C水平≥160mg/dL的参与者复合结局风险增加43%,心肌梗死风险高2.25倍。在使用他汀类药物者中,LDL-C水平>130mg/dL与复合结局风险增加相关。:本研究强调了透析患者LDL-C水平升高与不良心血管结局之间的显著关联。这些发现强调了在这一高危人群中密切监测和积极管理LDL-C水平的重要性。未来的研究应侧重于制定针对性的降脂策略,以改善这些患者的心血管结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ceb/12295821/a1a694b0b849/jcm-14-04845-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验